60 Degrees Pharmaceuticals (SXTP) Earnings Date & Reports

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SXTP is expected to report earnings to rise 67.78% to -150 cents per share on November 12

60 Degrees Pharmaceuticals SXTP Stock Earnings Reports

Q3'26

Est.

$-1.51

Q2'26

Beat

by $0.45

Q1'26

Beat

by $0.10

Q4'25

Missed

by $1.61

Q3'25

Missed

by $0.59

The last earnings report on August 19 showed earnings per share of -89 cents, beating the estimate of -135 cents. With 7.42K shares outstanding, the current market capitalization sits at 3.97M.

View a ticker or compare two or three

SXTP

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days